Appendiceal Goblet Cell Carcinoma: Role of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Overview

Journal Indian J Surg Oncol

Specialty Oncology

Date 2023 Jun 26

PMID 37359931

Authors

M Gaillard

P Van Eyken

G Verswijvel

K Van der Speeten

Affiliations

Soon will be listed here.

Abstract

Goblet cell carcinoma (GCC) encompasses a separate entity in appendiceal neoplasms with mixed glandular and neuro-endocrine pathological features. GCC mostly presents as an acute appendicitis duo to luminal obstruction or as an incidental finding on the surgical appendectomy specimen. In case of tumour perforation or presence of other risk factors, guidelines suggest additional treatment with a completing right hemicolectomy or cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). We report the case of a 77-year-old male with symptoms of appendicitis for which an appendectomy was performed. The appendix was ruptured during the procedure. There was an incidental finding of GCC on the pathological specimen. Because of possible tumour soiling, the patient received a prophylactic CRS-HIPEC. A literature review was performed to investigate the potential role for CRS-HIPEC as a curative treatment in patients with GCC. GCC of the appendix is an aggressive type of tumour with a high risk of peritoneal and systemic dissemination. CRS and HIPEC is a treatment option: both in a prophylactic setting and in patients with established peritoneal metastases.

References

Roy P, Chetty R . Goblet cell carcinoid tumors of the appendix: An overview. World J Gastrointest Oncol. 2010; 2(6):251-8. PMC: 2998842. DOI: 10.4251/wjgo.v2.i6.251. View

Yu H, Yonemura Y, Hsieh M, Mizumoto A, Wakama S, Lu C . Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center. Cancer Manag Res. 2017; 9:513-523. PMC: 5655158. DOI: 10.2147/CMAR.S147227. View

Elias D, Lefevre J, Chevalier J, Brouquet A, Marchal F, Classe J . Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2008; 27(5):681-5. DOI: 10.1200/JCO.2008.19.7160. View

Rossi R, Luong T, Caplin M, Thirlwell C, Meyer T, Garcia-Hernandez J . Goblet cell appendiceal tumors--management dilemmas and long-term outcomes. Surg Oncol. 2015; 24(1):47-53. DOI: 10.1016/j.suronc.2015.01.001. View

Radomski M, Pai R, Shuai Y, Ramalingam L, Jones H, Holtzman M . Curative Surgical Resection as a Component of Multimodality Therapy for Peritoneal Metastases from Goblet Cell Carcinoids. Ann Surg Oncol. 2016; 23(13):4338-4343. DOI: 10.1245/s10434-016-5412-z. View

Burke A, Sobin L, Federspiel B, Shekitka K, HELWIG E . Goblet cell carcinoids and related tumors of the vermiform appendix. Am J Clin Pathol. 1990; 94(1):27-35. DOI: 10.1093/ajcp/94.1.27. View

Madsen A, Ladekarl M, Villadsen G, Gronbaek H, Sorensen M, Stribolt K . Effects of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Goblet Cell Carcinoma: A Prospective Cohort Study. Ann Surg Oncol. 2017; 25(2):422-430. DOI: 10.1245/s10434-017-6272-x. View

Shyu S, Choudry H, Hall L, Pingpank J, Holtzman M, Bartlett D . Clinicopathological analysis of appendiceal goblet cell adenocarcinoma with peritoneal metastasis: World Health Organization grade predicts survival following cytoreductive surgery with intraperitoneal chemotherapy. Histopathology. 2020; 77(5):798-809. DOI: 10.1111/his.14189. View

Mahteme H, Sugarbaker P . Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin. Br J Surg. 2004; 91(9):1168-73. DOI: 10.1002/bjs.4609. View

10.

Huang D, Ren F, Ni S, Tan C, Weng W, Zhang M . Amphicrine carcinoma of the stomach and intestine: a clinicopathologic and pan-cancer transcriptome analysis of a distinct entity. Cancer Cell Int. 2019; 19:310. PMC: 6873408. DOI: 10.1186/s12935-019-1031-7. View

11.

Nagtegaal I, Odze R, Klimstra D, Paradis V, Rugge M, Schirmacher P . The 2019 WHO classification of tumours of the digestive system. Histopathology. 2019; 76(2):182-188. PMC: 7003895. DOI: 10.1111/his.13975. View

12.

Shenoy S . Goblet cell carcinoids of the appendix: Tumor biology, mutations and management strategies. World J Gastrointest Surg. 2016; 8(10):660-669. PMC: 5081547. DOI: 10.4240/wjgs.v8.i10.660. View

13.

Mo S, Zhou Z, Ying Z, Dai W, Xiang W, Han L . Epidemiology of and prognostic factors for appendiceal carcinomas: a retrospective, population-based study. Int J Colorectal Dis. 2019; 34(11):1915-1924. DOI: 10.1007/s00384-019-03387-y. View

14.

McCusker M, Cote T, Clegg L, Sobin L . Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998. Cancer. 2002; 94(12):3307-12. DOI: 10.1002/cncr.10589. View

15.

Fields A, Lu P, Enzinger A, Goldberg J, Irani J, Bleday R . Treatment patterns and outcomes in goblet cell carcinoid tumors of the appendix. J Surg Oncol. 2019; 120(7):1096-1101. PMC: 7428861. DOI: 10.1002/jso.25723. View

16.

Pham T, Wolff B, Abraham S, Drelichman E . Surgical and chemotherapy treatment outcomes of goblet cell carcinoid: a tertiary cancer center experience. Ann Surg Oncol. 2006; 13(3):370-6. DOI: 10.1245/ASO.2006.02.016. View

17.

Yozu M, Johncilla M, Srivastava A, Ryan D, Cusack J, Doyle L . Histologic and Outcome Study Supports Reclassifying Appendiceal Goblet Cell Carcinoids as Goblet Cell Adenocarcinomas, and Grading and Staging Similarly to Colonic Adenocarcinomas. Am J Surg Pathol. 2018; 42(7):898-910. DOI: 10.1097/PAS.0000000000001056. View

18.

Boudreaux J, Klimstra D, Hassan M, Woltering E, Jensen R, Goldsmith S . The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum. Pancreas. 2010; 39(6):753-66. DOI: 10.1097/MPA.0b013e3181ebb2a5. View

19.

Arai H, Baca Y, Battaglin F, Kawanishi N, Wang J, Soni S . Molecular Characterization of Appendiceal Goblet Cell Carcinoid. Mol Cancer Ther. 2020; 19(12):2634-2640. PMC: 8011958. DOI: 10.1158/1535-7163.MCT-20-0318. View

20.

. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms. Ann Surg Oncol. 2020; 27(6):1753-1760. DOI: 10.1245/s10434-020-08316-w. View